Neurology Clinic D, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Epigenetics Group, International Agency for Research on Cancer, Lyon, France.
Eur J Clin Invest. 2018 Jun;48(6):e12933. doi: 10.1111/eci.12933. Epub 2018 May 13.
Cancer is believed to arise through the perturbation of pathways and the order of pathway perturbation events can enhance understanding and evaluation of carcinogenicity. This order has not been examined so far, and this study aimed to fill this gap by attempting to gather evidence on the potential temporal sequence of events in carcinogenesis.
The methodology followed was to discuss first the temporal sequence of hallmarks of cancer from the point of view of pathological specimens of cancer (essentially branched mutations) and then to consider the hallmarks of cancer that one well-known carcinogen, benzo(a)pyrene, can modify.
Even though the sequential order of driving genetic alterations can vary between and within tumours, the main cancer pathways affected are almost ubiquitous and follow a generally common sequence: resisting cell death, insensitivity to antigrowth signals, sustained proliferation, deregulated energetics, replicative immortality and activation of invasion and metastasis. The first 3 hallmarks can be regarded as almost simultaneous while angiogenesis and avoiding immune destruction are perhaps the only hallmarks with a varying position in the above sequence.
Our review of hallmarks of cancer and their temporal sequence, based on mutational spectra in biopsies from different cancer sites, allowed us to propose a hypothetical temporal sequence of the hallmarks. This sequence can add molecular support to the evaluation of an agent as a carcinogen as it can be used as a conceptual framework for organising and evaluating the strength of existing evidence.
癌症被认为是通过途径的扰动而产生的,而途径扰动事件的顺序可以增强对致癌性的理解和评估。到目前为止,还没有对这种顺序进行检查,本研究旨在通过尝试收集致癌作用中潜在事件时间顺序的证据来填补这一空白。
所遵循的方法是首先从癌症病理标本(本质上是分支突变)的角度讨论癌症标志的时间顺序,然后考虑一种已知致癌剂苯并(a)芘可以修饰的癌症标志。
尽管驱动遗传改变的顺序在肿瘤之间和肿瘤内可能有所不同,但受影响的主要癌症途径几乎无处不在,并遵循一个普遍的共同顺序:抵抗细胞死亡、对生长信号不敏感、持续增殖、能量失调、复制永生和侵袭转移的激活。前 3 个标志可以被认为几乎是同时发生的,而血管生成和避免免疫破坏可能是上述顺序中唯一位置不同的标志。
我们根据来自不同癌症部位活检的突变谱对癌症标志及其时间顺序进行了综述,从而提出了一个标志的假设时间顺序。该序列可以为评估致癌剂作为致癌剂提供分子支持,因为它可用作组织和评估现有证据强度的概念框架。